High Vascular Delivery of EGF, but Low Receptor Binding Rate Is Observed in AsPC-1 Tumors as Compared to Normal Pancreas

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations

Medicine, Oncology, Pharmacology +17

Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts

Paul S. Tofts, Allan G. Kermode · Magnetic Resonance in Medicine · 1991 · 1.5K citations

Medicine, Neuroscience, Radiology +17

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality <i>in vivo</i> imaging

Derek W. Bartlett, Helen C. Su, Isabel J. Hildebrandt et al. · Proceedings of the National Academy of Sciences · 2007 · 797 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

Siegfried Segaert, Eric Van Cutsem · Annals of Oncology · 2005 · 574 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +16

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands

Andreas Becker, Carsten Hessenius, Kai Licha et al. · Nature Biotechnology · 2001 · 520 citations

Medicine, Biomedical Engineering, Oncology +14